| Identification |
| Name: | N~2~-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-N-(2-methyl-4-oxoquinazolin-3(4H)-yl)glycinamide |
| Synonyms: | BRN 4338966;1,3,4-Oxadiazole-2-acetamide, 2-(p-flourophenyl)-N-(2-methyl-4-oxo-3(4H)-quinazolinyl)-;Acetamide, 2-((5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)amino)-N-(2-methyl-4-oxo-3(4H)-quinazolinyl)-;AC1MIQJG;LS-9640;135790-29-3;2-[[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]amino]-N-(2-methyl-4-oxoquinazolin-3-yl)acetamide |
| CAS: | 135790-29-3 |
| Molecular Formula: | C19H15FN6O3 |
| Molecular Weight: | 394.3592 |
| InChI: | InChI=1/C19H15FN6O3/c1-11-22-15-5-3-2-4-14(15)18(28)26(11)25-16(27)10-21-19-24-23-17(29-19)12-6-8-13(20)9-7-12/h2-9H,10H2,1H3,(H,21,24)(H,25,27) |
| Molecular Structure: |
 |
| Properties |
| Density: | 1.5g/cm3 |
| Refractive index: | 1.707 |
| Safety Data |
| |
 |
